Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 232 clinical trials
Featured trial
Build 10 Formal Testing

Build 10 Formal Testing

  • 0 views
  • 19 Feb, 2024
Featured trial
Virtual Trial 01  

Test Comment here 

Accepts healthy volunteers
  • 0 views
  • 19 Feb, 2024
  • 1 location
Featured trial
A5418 Study of Tecovirimat for Human Monkeypox Virus (STOMP)  

This study will determine if the drug, tecovirimat, helps treat people you are infected with monkeypox virus. You must be 18 years of age or older to participate. You must have a positive laboratory test for monkeypox virus within 14 days of enrolling in the study and at least one …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Featured trial
test website import(please dont visit)  

Here is the indented text testing testing testingStudents can find all their necessary study materials and learning resources at Vedantu. Along with the Essay on Mothers, students can also find various other Essays on different topics with two ranges of both long and short examples. For more information and details, …

  • 0 views
  • 27 Sep, 2024
  • 2 locations
Featured trial
  • 0 views
  • 19 Mar, 2025
  • 1 location
Featured trial
  • 0 views
  • 09 Aug, 2024
  • 1 location
Featured trial
test23  

uuu

Accepts healthy volunteers
  • 0 views
  • 18 Mar, 2025
  • 2 locations
RJ_StudyVirtualF  

Acne

Online studies
  • 0 views
  • 19 Feb, 2024
  • 1 location
  • Online study
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

The purpose of this study is to evaluate the efficacy and safety of lenvatinib and pembrolizumab in combination with TACE versus TACE plus oral and intravenous (IV) placebos in participants with incurable, non-metastatic hepatocellular carcinoma (HCC). The primary hypotheses are that pembrolizumab plus lenvatinib in combination with TACE is superior …

hcv infection
pembrolizumab
chemoembolization
hepatitis b
hepatitis
  • 0 views
  • 19 Feb, 2024
Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors

The primary objective of the trial is to evaluate the antitumor activity of atezolizumab and rucaparib in patients with selected advanced solid tumors as measured by the Overall Response Rate

granulocyte colony stimulating factor
hormonal contraception
metastatic disease
progesterone
periodic abstinence
  • 0 views
  • 19 Feb, 2024